Description
CoviRAT
Rapid Test for Detection of SARS-CoV-2 Antigen in Human
Nasopharyngeal Swab Specimens
CoviRAT is an invitro, rapid, qualitative immunoassay for the detection of nucleocapsid protein antigens expressed by the SARSCoV2 virus present in human nasopharyngeal swab specimen. It is to be used for screening or to aid in the diagnosis of COVID19 and takes 1530 minutes for producing test result. Rapid antigen tests are known to be sensitive enough to detect clinical cases, i.e. presymptomatic and early symptomatic cases (up to five days from symptom onset; or low RTPCR cycle threshold (Ct) value <30), which likely account for a significant proportion
of transmissions. The use of sensitive and specific rapid antigen test is appropriate in high prevalence areas as well as in low prevalence areas to identify the infectious positive cases. Rapid antigen tests can help reduce further transmission through early identification of positive cases, enabling a faster contact tracing
| FEATURES | BENEFITS |
|---|---|
| Double Antibody Sandwich Assay. | Detects nucleocapsid protein antigens expressed by SARSCoV2 virus. |
| Monoclonal antibodies used in both capture and tracer part. |
Detects nucleocapsid protein antigens expressed by SARSCoV2 virus. |
| Nasopharyngeal specimen can be used. |
Facilitates higher volume testing at the patient site and in laboratory setup. |
| Rapid Antigen Detection Test. | Results in 1530 minutes. |
| Sterile Breakable nasopharyngeal swabs |
Minimizes exposure. Ease of use. |
| Sensitivity 96.3%* Specificity 100% |
Highly Sensitive and Accurate test result ; compared to RTPCR ! |
Reviews
There are no reviews yet.